InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,864.67
(
0.40%
)
US TECH 100
19,783.20
(
0.68%
)
Dow Jones
43,275.91
(
0.09%
)
Brent Oil
72.95
(
0.01%
)
Bitcoin
69,053.63
(
1.01%
)
Post# of 94785
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

BiotechValues

Send PM Follow Ignore
Followers 355
Posts 9910
Boards Moderated 2
Alias Born 06/23/2007

BiotechValues

Re: derek2000 post# 43675

Monday, 06/21/2010 9:53:18 AM

Monday, June 21, 2010 9:53:18 AM

Post# of 94785
interesting response on YONG by C. Coulson.

I'm not sure they did a good job of making it "very clear" that this $30M expense is an advantageous move for the company and shareholders.

It begs the question: "Shouldn't they already have had control over the distribution channel and access to the customer list?"

Maybe I'm missing something?



“The 19th century belonged to England, the 20th century belonged to the U.S., and the 21st century belongs to China. Invest accordingly.”

Warren Buffett

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up